Toxicologic Pathology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Povey, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Povey, A. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Toxicologic Pathology, Vol. 28, No. 3, 405-414 (2000)
DOI: 10.1177/019262330002800308

DNA Adducts: Endogenous and Induced

Andrew C. Povey

School of Epidemiology and Health Sciences, University of Manchester, Manchester, United Kingdom

Human exposure to DNA damaging agents can arise from exogenous sources or endogenous processes that occur normally or in pathological states. DNA isolated from human tissues, obtained from the very young to the old, contains detectable amounts of a number of different types of DNA adducts that reflect exposure to both known carcinogens and as yet unidentified genotoxic agents. The levels of DNA damage observed in human studies as a result of exogenous exposures (noniatrogenic) is of the order of 1 adduct per 107-109 normal DNA bases, whereas that arising from endogenous exposures may potentially be several orders of magnitude higher. Large interindividual variations in DNA adduct levels have been reported, and these are probably the result of host and environmental factors, although variation in analytical and sampling procedures may also play a role. It is important to recognize that the presence of DNA adducts in a tissue does not necessarily indicate a specific tumorigenic risk for that tissue, as other factors downstream of DNA adduct formation (including DNA repair and cell proliferation) play an important role in determining overall risk.

Key Words: DNA adducts • 8-hydroxyguanine • O6-methylguanine • bulky DNA adducts • carcinogen exposure


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
B. L. Schneider and M. Kulesz-Martin
Destructive cycles: the role of genomic instability and adaptation in carcinogenesis
Carcinogenesis, November 1, 2004; 25(11): 2033 - 2044.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
H. W. Mohrenweiser
Genetic Variation and Exposure Related Risk Estimation: Will Toxicology Enter a New Era? DNA Repair and Cancer as a Paradigm
Toxicol Pathol, January 1, 2004; 32(1_suppl): 136 - 145.
[Abstract] [PDF]


Home page
GutHome page
S A Khan, P L Carmichael, S D Taylor-Robinson, N Habib, and H C Thomas
DNA adducts, detected by 32P postlabelling, in human cholangiocarcinoma
Gut, April 1, 2003; 52(4): 586 - 591.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. E. Jackson, P. J. O'Connor, D. P. Cooper, G. P. Margison, and A. C. Povey
Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine
Carcinogenesis, March 1, 2003; 24(3): 527 - 533.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
G. P. Margison, M. F. Santibanez Koref, and A. C. Povey
Mechanisms of carcinogenicity/chemotherapy by O6-methylguanine
Mutagenesis, November 1, 2002; 17(6): 483 - 487.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
L. Tryphonas and C. Gopinath
A Synopsis of the Third International Federation of Societies of Toxicologic Pathologists Conference
Toxicol Pathol, May 1, 2000; 28(3): 370 - 374.
[PDF]


Home page
Toxicol PatholHome page
P. J. O'Connor, F. C.R. Manning, A. T. Gordon, M. A. Billett, D. P. Cooper, R. H. Elder, and G. P. Margison
Thresholds for Genotoxic Carcinogens: DNA Repair: Kinetics and Thresholds
Toxicol Pathol, May 1, 2000; 28(3): 375 - 381.
[Abstract] [PDF]